Institute for Myeloma and Bone Cancer Research Adds Two New Board Members

LOS ANGELES--(Business Wire)--
The Institute for Myeloma and Bone Cancer Research, an independent
non-profit cancer research institute headquartered in Los Angeles,
added Roger Fischer and Alvin Dischler to its Board of Directors.

"The two new board members, Roger Fischer and Alvin Dischler, add
to our board depth of management," said James R. Berenson, MD,
President and CEO for the Institute for Myeloma and Bone Cancer
Research. "Roger Fischer's work in the field of healthcare marketing
is essential as we promote awareness of our cancer research
initiatives. Alvin Dischler's participation on our board will provide
additional expertise and business acumen to help us increase our
leadership position as an independent cancer research institute."

Roger Fischer is the founder of FischerHealth, a Porter Novelli
Company, a member of Omnicom Group (NYSE: OMC). Roger is a 25 year
veteran in healthcare marketing and communications strategy.

Alvin L. Dischler was Vice President of May Department Stores.
Dischler has been an established force in the business world and has
owned and operated a number of small and large businesses throughout
Los Angeles including office buildings and industrial parks. Alvin
served on the Jewish Federation of Greater Los Angeles' Western Region
Board, on the Board of University Synagogue in Brentwood/Los Angeles
and was Treasurer and President of Adat Shalom Synagogue in Los
Angeles, California.

The Institute for Myeloma and Bone Cancer Research (IMBCR) is an
independent, non-profit cancer research institute located in Los
Angeles, California. The goal of the Institute is to develop new and
cutting-edge therapies to improve the quality of life and longevity of
patients with myeloma and other hematologic cancers. www.imbcr.org

The Rogers Group
Ron Rogers, 310-552-4100
rrogers@rogerspr.com

Copyright Business Wire 2008